Key result
Higher superoxide dismutase activity is linked to ~35% lower risk of reduced LVEF in diabetic ACS.
Why the study?
No previous study had assessed the value of superoxide dismutase (SOD) and inflammatory markers together as predictive indicators of heart failure in patients with diabetes and ACS.
Does SOD activity, CRP, or fibrinogen predict reduced LVEF in patients with diabetes and acute coronary syndrome?
Cross-Sectional (n=2,377)
No
Does SOD activity, CRP, or fibrinogen predict reduced LVEF in patients with diabetes and acute coronary syndrome?
Effect estimate: OR 0.651 (95% CI 0.482-0.880)
p-value: p=0.005
SOD activity is a stronger independent predictor of reduced LVEF than CRP and fibrinogen in patients with type 2 diabetes and acute coronary syndrome.
Background: Superoxide dismutase (SOD) and inflammatory markers are reported to have association with cardiovascular disease. However, no previous study has assessed the value of SOD and inflammatory markers as predictive indicator of heart failure in patients with diabetes and acute coronary syndrome (ACS) in the same study. Objective: The objective of this study is to compare the predictive implications of SOD activity, C-reactive protein (CRP) and fibrinogen for reduced left ventricular ejection fraction (LVEF) in patients with diabetes and ACS. Method: The study included 2377 inpatients with type 2 diabetes who had an ACS admitted to the Shandong Provincial Hospital affiliated to Shandong First Medical University from January 2016 to January 2021. Result: Despite taking the lowest quartile as reference (OR 0.368, 95% CI 0.493–0.825, P = 0.001) or examining 1 normalized unit increase (OR 0.651, 95% CI 0.482–0.880, P = 0.005), the SOD activity was exhibited to be the strongest predictive indicator of reduced LVEF, independent of confounding factors. The SOD activity showed the most powerful predictor value for reduced LVEF with the highest area under the receiver operating characteristic curve of 0.658. Conclusions: SOD activity is a stronger predictor of reduced LVEF than CRP and fibrinogen in patients with diabetes and ACS.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2022) conducted a cross-sectional in Type 2 diabetes with acute coronary syndrome (n=2,377). Superoxide dismutase (SOD) activity was evaluated on Reduced left ventricular ejection fraction (LVEF ≤ 45%) (OR 0.651, 95% CI 0.482-0.880, p=0.005). Higher superoxide dismutase activity was independently associated with a lower risk of reduced left ventricular ejection fraction (OR 0.651) in patients with diabetes and acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: